Grega G J, Adamski S W
Department of Pharmacology, University of Houston, Science & Research II, Texas 77204-5515.
Microcirc Endothelium Lymphatics. 1991;7(4-6):267-91.
The suffused noneverted cheek pouch of pentobarbital anesthetized hamsters was used to study the effects of localized, selective mast cell degranulation on vascular permeability. Fluorescein isothiocynate dextran (FITC-D, 70,000 Da) was utilized as a tracer, and intra-vital light microscopy was employed to monitor the formation of vascular leakage sites while direct measurement of plasma and suffusate tracer concentrations were used to monitor tracer clearance. Varying the time at which the FITC-D tracer was injected i.v. relative to the start of the Compound 48/80 suffusion permitted direct determination of the duration of any observed increase in vascular permeability. Selective, local mast cell degranulation was triggered by suffusing the cheek pouch with Compound 48/80 for 10 minutes which stimulated the formation of focal FITC-D leakage sites in the postcapillary venules resulting in increases in [FITC-D]S, [FITC-D]S/[FITC-D]P. 10(-6), and FITC-D clearance. In contrast, suffusion of the cheek pouches with saline failed to trigger the formation of venular FITC-D leakage sites or to promote increases in [FITC-D]S, [FITC-D]S/[FITC-D]P. 10(-6), and FITC-D clearance. The increase in permeability produced by Compound 48/80 was marked but transient (duration less than 20 minutes), and subject to inhibition by treatment with either the H1 receptor antagonist diphenhydramine or the endothelial cell stabilizer isoproterenol. There was no evidence for for a non-histamine mediated or delayed-onset increase in vascular permeability to macromolecules during the course of these experiments.
用戊巴比妥麻醉的仓鼠充血未翻转的颊囊来研究局部、选择性肥大细胞脱颗粒对血管通透性的影响。异硫氰酸荧光素葡聚糖(FITC-D,70,000道尔顿)用作示踪剂,采用活体光学显微镜监测血管渗漏部位的形成,同时通过直接测量血浆和灌洗液中示踪剂浓度来监测示踪剂清除情况。相对于48/80化合物灌注开始的时间,改变静脉注射FITC-D示踪剂的时间,可以直接确定观察到的血管通透性增加的持续时间。通过用48/80化合物灌注颊囊10分钟来触发选择性、局部肥大细胞脱颗粒,这刺激了毛细血管后微静脉中局灶性FITC-D渗漏部位的形成,导致[FITC-D]S、[FITC-D]S/[FITC-D]P.10(-6)和FITC-D清除率增加。相比之下,用盐水灌注颊囊未能触发微静脉FITC-D渗漏部位的形成,也未能促进[FITC-D]S、[FITC-D]S/[FITC-D]P.10(-6)和FITC-D清除率的增加。48/80化合物引起的通透性增加显著但短暂(持续时间少于20分钟),并且可被H1受体拮抗剂苯海拉明或内皮细胞稳定剂异丙肾上腺素治疗所抑制。在这些实验过程中,没有证据表明存在非组胺介导的或延迟发作的对大分子的血管通透性增加。